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Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is complicated disease and increasing worldwide. Previously,
many studies of NALFD prevalences have used alanine aminotransferase (ALT) of > 40 U/L to define NAFLD,
although that is too high to be reliable among adolescents. This study aimed to define the upper normal
limit of ALT among Korean adolescents, and use it to estimate the prevalence of NAFLD, based on data from
the Korea National Health and Nutrition Examination Survey (KNHANES).
Methods: Data were obtained from 1785 healthy adolescents (916 boys and 869 girls, 10–18 years old) who
participated in the KNHANES during 2010–2015. The International Diabetes Federation metabolic syndrome
criteria for adolescents were used to exclude participants with metabolic syndrome components. Furthermore,
participants who previously had diseases related to low HDL levels, high TG levels, diabetes, or very low/high
body mass index and hepatitis B were excluded. The 95th percentiles level of ALT from healthy participants
were evaluated. The definition of NAFLD was overweight status (≥85th percentile of body mass index) plus
elevated ALT levels (95th percentile).
Results: The upper normal ALT were 24.1 U/L for boys and 17.7 U/L for girls. Based on these values, the estimated
prevalences of NAFLD in 2015 were 8.9% among adolescents.
Conclusion: Defining the upper normal limit of ALT can be adjusted for each sex and ethnics in the general
population. ALT laboratory thresholds used for children should be re-examined. The physicians should be aware
not to underdiagnose NAFLD patient even ALT level is < 40 U/L.
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Background
General and specific background
The prevalence of non-alcoholic fatty liver disease (NAFLD)
is increasing worldwide. [1] Therefore, it is necessary for
obese adolescents to be actively examined for NAFLD. And
symptoms and clinical signs, laboratory and radiological im-
aging test, and liver biopsy is needed to make diagnosis
finally as NAFLD. [2, 3] But in general population, it is not
possible to perform all diagnostic procedures for each
people. Therefore, Alanine aminotransferase (ALT) is used
to find prevalence in general populations. ALT is an enzyme
that is found in the cytosol of hepatocytes, and blood levels
of ALT increase after liver injury [4]. Thus, blood testing for
ALT is used globally as a minimally invasive and inexpen-
sive tool for detecting chronic liver diseases, such as
non-alcoholic fatty liver disease (NAFLD) [1].
Debating issue
However, the reference ranges for normal ALT vary
widely across different laboratories and populations [1].
Among adults, the upper normal limit of ALT was de-
rived from healthy Italian blood donors, with values of
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30 U/L for men and 19 U/L for women [5]. Among
American adolescents, the upper normal limit of ALT
was estimated by the National Health and Nutrition
Examination Survey to be 25.8 U/L for boys and 22.1 U/
L for girls [6, 7].
Specific purpose of this study
Nevertheless, population differences indicate that these
values may not be the same among Korean adolescents.
However, the method used to define NAFLD in this
study is only tools to estimated NAFLD in public popu-
lations, so this result cannot directly be used in clinic.
But result of this study will give clues to evaluate and
manage NAFLD in clinic. Therefore, the present study
aimed to estimate the upper normal limits of ALT
among Korean adolescents, as well as the prevalences of
NAFLD based on those values.
Methods
Database
The present study evaluated data from the 2010–2015
Korea National Health and Nutrition Examination
Survey (KNHANES). These annual cross-sectional
surveys are performed using multi-stage probability
samples that are representative of the general Korean
population. The data of KNHANES surveys are avail-
able at http://knhanes.cdc.go.kr/.
Study sample.
During 2010–2015, 48,482 individuals participated in the
KNHANES. The present study included participants
who were 10–18 years old, but excluded participants
with missing data and metabolic syndrome components,
based on the International Diabetes Federation consen-
sus definition (www.idf.org). Furthermore, 10–15-year--
old participants were excluded if they had a waist
circumference of ≥90th percentile for sex and age, trigly-
ceride (TG) levels of ≥150 mg/dL, high density lipopro-
tein (HDL) levels of < 40 mg/dL, systolic blood pressure
(SBP) of ≥130 mmHg, diastolic blood pressure (DBP) of
≥85 mmHg, and glucose levels of ≥100 mg/dL. More-
over, participants who were 16–18-years-old were
excluded if they had a waist circumference of ≥90 cm or
HDL levels of < 40 mg/dL (boys), a waist circumference
of ≥80 cm or HDL levels of < 50 mg/dL (girls), TG levels
of ≥150 mg/dL, SBP of ≥130 mmHg, DBP of ≥85 mmHg,
and glucose levels of ≥100 mg/dL. Finally, we excluded
participants who previously had diseases related to low
HDL levels, high TG levels, diabetes, or very low/high
body mass index (BMI, <5th percentile or > 85th per-
centile) [8]. Furthermore, participants who had hepatitis
B infection were excluded. Thus, 1785 healthy partici-
pants (916 boys and 869 girls) were included in the ana-
lysis to determine the upper normal limit of ALT. For
the present study, NAFLD was defined as being over-
weight (≥85th percentile of BMI) plus having elevated
ALT (≥95th percentile, 24.1 U/L for boys and 17.7 U/L
for girls). A total of 4149 participants (2226 boys and
1923 girls) were included in the analyses to estimate the
prevalence of NAFLD (Figure 1) [9].
Statistical analysis
All statistical analyses were performed using SPSS soft-
ware (version 23.0; IBM Inc., Armonk, NY). Categorical
Fig. 1 Flow chart for participant selection (916 boys, 869 girls)
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data were collected for healthy participants (without meta-
bolic syndrome components), and continuous laboratory
and anthropometry data were expressed as mean ± stand-
ard error. The 95th percentiles for ALT were estimated
for each sex using weighted analysis, and those values
were used to estimate the prevalences of NAFLD among
adolescents who participated in KNHANES and had avail-
able BMI and ALT data.
Results
Characteristics of the healthy participants
The characteristics of the 1785 healthy participants (916
boys and 869 girls) are shown in Table 1. All characteristics
appeared to be within the normal ranges, and the mean
ALT levels were 14.2 U/L for boys and 10.9 U/L for girls.
The 95th percentiles for ALT among healthy participants
were 24.1 U/L for boys and 17.7 U/L for girls (Figure 2a).
Prevalence of elevated ALT among Korean adolescents
A total of 4149 KNHANES participants had available
ALT and BMI data. Among all participants during 2010–
2015, the estimated prevalence of elevated ALT levels
was 10.9% (95% confidence interval [CI]: 9.8–12.1%).
During 2015, the overall estimated prevalence of ele-
vated ALT levels was 13.7% (95% CI: 11.0–15.5%). In
addition, the estimated prevalences of elevated ALT
levels during 2015 were 14.9% (95% CI: 11.0–19.8%) for
boys and 12.3% (95% CI: 8.6–17.3%) for girls (Figure 2b).
Prevalence of NAFLD among Korean adolescents
The prevalence of NAFLD was estimated using the 95th
percentile values for ALT (24.1 U/L for boys and 17.7 U/
L for girls) plus the age- and sex-specific 85th percentile
values for BMI. During 2015, the overall prevalence of
NAFLD was 8.9% (95% CI: 6.7–11.6%), with prevalences
of 10.8% (95% CI: 7.7–15.0%) among boys and 6.6%
(95% CI: 4.0–10.9%) among girls (Figure 3).
Discussion
The present study evaluated data from the general popu-
lation of healthy Korean adolescents to estimate the
upper normal limit of ALT. The results indicate that the
upper limits (95th percentiles) for estimating the preva-
lence of NAFLD in this population were 24.1 U/L for
boys and 17.7 U/L for girls. These values are similar to,
albeit lower than, the values among American adoles-
cents (25.8 U/L for boys, 22.1 U/L for girls) [6].
The present study used the upper normal limit of
ALT to estimate the prevalence of NAFLD, which re-
vealed values of 10.8% among boys and 6.6% among
girls in 2015. In contrast, use of the previous standard
values (30 U/L for boys and 19 U/L for girls) generated
estimated NAFLD prevalences of 6.7% among Korean
boys and 5.1% among Korean girls in 2015 [10] [5, 11].
Thus, the prevalence of NAFLD in this population
appears to be unexpectedly high, and we recommend
aggressive management for patients who may have un-
detected NAFLD based on the previous standard ALT
values.
The prevalence of NAFLD (elevated ALT levels (>
30 U/L)) was 3.6% in boys and 2.8% in girls from 1594
adolescents aged 10 to 19 years using the 1998
KNHANES. [12] The prevalence of NAFLD in Chinese
children found out to be 9.03% with ALT thresholds >
25.8 U/L for boys > 22.1 U/L for girls using China
Health and Nutrition Surveys. [13] Although there is a
lack of uniformity in the data, but similar results were
obtained with studies conducted in China from our
study. Emma et al. pooled prevalence of NAFLD as 7.6%
(95%CI: 5.5 to 10.3%) using meta-analysis and showed
that it did not differ by geographical region among chil-
dren and adolescents. [14, 15] Even with heterogenicity
of defining NALFD across studies, it seems that the
prevalence of NAFLD increase with time and has glo-
bally similar prevalence.
This study had some important limitations. First, we
used elevated ALT plus elevated BMI as criteria to diag-
nose NAFLD. Some NAFLD patients may have normal
ALT levels and it does not parallelly match the histo-
logical severity of NAFLD in children. [16] So, in order
to diagnose NALFD, imaging investigations or histology
confirmation should be included. However, we have not
been able to confirm NAFLD using imaging investiga-
tion in this cohort study as it has not been used in every
cycle of KNHANES. Therefore, it could not be included
in the criteria of NAFLD in this study. However, ALT
Table 1 The characteristics of healthy KNHANES participants
during 2010–2015
Total Male Female
Age(year) 13.98 ± 0.07 13.98 ± 0.10 13.99 ± 0.10
SBP(mmHg) 105.39 ± 0.28 107.01 ± 0.41 103.78 ± 0.35
DBP(mmHg) 64.99 ± 0.27 64.98 ± 0.41 65.00 ± 0.32
Height(cm) 160.12 ± 0.30 163.54 ± 0.50 156.70 ± 0.31
Weight(kg) 50.35 ± 0.29 53.06 ± 0.49 47.63 ± 0.30
Waist(cm) 66.24 ± 0.18 67.77 ± 0.27 64.70 ± 0.22
BMI(kg/m2) 19.41 ± 0.06 19.56 ± 0.10 19.26 ± 0.07
Glucose(mg/dl) 88.52 ± 0.17 89.00 ± 0.22 88.04 ± 0.22
Cholesterol(mg/dl) 158.80 ± 0.74 152.82 ± 1.01 164.79 ± 1.06
HDL(mg/dl) 55.06 ± 0.29 53.54 ± 0.39 56.57 ± 0.40
TG(mg/dl) 68.76 ± 0.78 66.42 ± 1.09 71.11 ± 1.07
AST(U/L) 18.60 ± 0.15 20.02 ± 0.22 17.18 ± 0.17
ALT(U/L) 12.56 ± 0.18 14.18 ± 0.30 10.94 ± 0.19
Data are presented as mean ± standard error
SBP Systolic blood pressure, DBP Diastolic blood pressure, BMI Body mass
index, HDL High-density lipoprotein, TG Triglycerides, AST Aspartate
aminotransferase, ALT Alanine aminotransferase
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has been recommended as a screening tool for NAFLD
and has previously been used for population-based epi-
demiological studies. [7, 8, 17] Furthermore, the upper
normal limits of ALT (24.1 U/L for boys and 17.7 U/L
for girls) should be validated using liver biopsies [7, 18].
Second, the KNHANES data do not include information
regarding the use of hepatotoxic medication. Third,
although ours is the most recent study to estimate the
sex-specific upper normal limits of ALT among Korean
adolescents, additional criteria should be considered
when using ALT levels to estimate the prevalences of
other chronic liver diseases in Korea. As we mentioned
at the beginning, NAFLD should be diagnosed using
liver biopsy or imaging studies. So, results from present
study cannot directly be used in clinic level.
However, even with these limitation, this is first study
to define upper normal ALT level of adolescents by
using KHANES data. And according to our data, preva-
lences of adolescents NAFLD in Korea might be more
serious than we used to think. As the result of this study
shows normal value of ALT can varies by some circum-
stances, ALT laboratory thresholds used for children
should be re-examined. The physicians should be aware
not to underdiagnose NAFLD patient when ALT level is
Fig. 2 Trends in the 95th percentiles for alanine aminotransferase (a) and the prevalence of participants with elevated alanine aminotransferase
(>95th percentile) (b)
Fig. 3 The estimated prevalence of non-alcoholic fatty liver disease among Korean adolescents
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in normal value we used to use in clinic. However, the
defining NAFLD (BMI ≥ 85th percentile plus elevated
ALT) used in the study is only tools to estimate NAFLD
in public populations, so this upper normal ALT results
cannot directly be used in clinic. We hope these results
can give clues that ALT level can be adjusted for each
sex and ethnics. And ALT could be more useful tool to
determine who may need more detailed medical exami-
nations for NAFLD if ALT is adjusted specific for each
ethnics and sex.
Conclusions
The upper normal level of ALT in Korea were 24.1 U/L
for boys and 17.7 U/L for girls in our study. And based on
the weighting of the KNHANES design, our estimates in-
dicate that NAFLD may be present in year 2015, approxi-
mately 282,981 adolescent boys and 159,154 adolescent
girls. Thus, additional care is needed to identify Korean
adolescents with undetected NAFLD and its complica-
tions. And further study is needed for evaluating sensitiv-
ity and specificity of upper normal level of ALT from this
study.
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